Try our Advanced Search for more refined results
Securities
-
January 16, 2026
Lifecore Investors Ink $3.8M Deal In Accounting Controls Suit
Biotech company Lifecore Biomedical Inc. has reached a $3.8 million deal with its investors to end their claims the company had weak controls over its financial reporting, impairing its ability to remain compliant with Nasdaq listing requirements and causing share declines.
-
January 16, 2026
6th Circ. Revives Biomed Co. Investor's Suit Over Stock Sale
The Sixth Circuit has ruled that a man who sold his stock in a biomedical research company just before being told the company planned to pursue private equity financing can bring his breach of contract and fiduciary duty claims, reversing a lower court's ruling granting summary judgment to the biomedical company.
-
January 16, 2026
$29M Deal In Boeing Supplier Fraud Suit Gets Final OK
A New York federal judge on Friday approved a $29 million deal to close out a suit alleging that Spirit AeroSystems Holdings Inc. misled investors by failing to disclose pervasive quality problems and a documented history of supplying its chief customer, The Boeing Co., with defective plane parts.
-
January 16, 2026
SIFMA Presses SEC To Reverse Nasdaq Fee Hike
The Securities Industry and Financial Markets Association is urging the U.S. Securities and Exchange Commission to force Nasdaq and other exchanges to stop collecting new fees that the organization argues were allowed to go live with little detail as to why they were necessary or how they comply with the law and past SEC guidance.
-
January 16, 2026
Acadia Investors Get Initial OK For $179M Settlement
Acadia Healthcare Co. Inc. investors have received the first OK from a Tennessee federal judge for a $179 million settlement in a class action alleging the company misled them about the strength of its U.K. operations.
-
January 16, 2026
Pomerantz To Lead Biohaven Investors' FDA Approval Suit
Pomerantz LLP will lead a proposed class of investors accusing biopharmaceutical company Biohaven Ltd. of overstating the odds that two of its product candidates would receive regulatory approval, a Connecticut judge said Friday.
-
January 16, 2026
Judge Yanks $41M Atty Fee Award In SPAC Merger Suit
A Texas federal judge has rescinded an attorney fee award of over $41 million to Robbins Geller Rudman & Dowd LLP, Labaton Keller Sucharow LLP and Entwistle & Cappucci LLP after the firms became engaged in a dispute over the amount of work done and the allocation of fees, among other things.
-
January 16, 2026
7th Circ. Won't Revive Investment Cos.' VIX-Fix Claims
The Seventh Circuit on Thursday affirmed the dismissal of two investment companies' volatility index manipulation claims against Barclays, Morgan & Stanley Co. and other financial institutions, agreeing with a lower court that one lacked standing and the other missed a statutory deadline.
-
January 16, 2026
High Court Takes Up Intel Workers' Bid To Revive 401(k) Suit
The U.S. Supreme Court agreed Friday to hear Intel workers' challenge to a Ninth Circuit decision backing an end to their proposed class action alleging 401(k) mismanagement, a case that gives the justices a chance to clarify the pleading standards for retirement fund underperformance.
-
January 16, 2026
Insurer Says Other Carrier Owes $23M For Old Policy Claims
Sparta Insurance Co. said the former parent of an insurer it acquired reneged on its contractual obligations to handle and pay claims under policies issued before the acquisition, telling a Massachusetts federal court that it is owed more than $23 million in settlement payments, attorney fees and other costs.
-
January 15, 2026
NCAA Urges Feds, States To Rein In College Sports Wagers
The NCAA has urged a federal regulator to suspend prediction market trades based on college sports until appropriate safeguards are in place and called on state gambling commissions to restrict certain types of wagers, saying it knows they are being manipulated.
-
January 15, 2026
SEC Says Healthcare Exec Misspent $10.6M In Investor Funds
The U.S. Securities and Exchange Commission on Thursday accused a healthcare company CEO of misappropriating over $10 million from investors by falsely claiming the funds would be used to develop cancer screening and treatment technology when in fact they were spent on credit card debt, luxury vehicles and strip club visits.
-
January 15, 2026
Getty Loses 2nd Circ. Bid Over $88M Stock Sale Breach Order
A divided Second Circuit on Thursday upheld a ruling requiring Getty Images to pay out nearly $88 million to investors who said they were blocked from purchasing shares in the company once it became public, finding Getty breached a contract promising the investors those shares.
-
January 15, 2026
Musk Slams SEC's 'Premature' Bid For Twitter Buy-Up Win
The U.S. Securities and Exchange Commission shouldn't be handed an early win on its claims Elon Musk didn't make timely disclosures of his stake in Twitter when the regulator hasn't yet produced discovery in the matter, the tech billionaire has argued.
-
January 15, 2026
Dechert Adds Ex-NYC Deputy Mayor To Co-Lead Trial Practice
Dechert LLP announced Thursday that it has hired veteran trial lawyer Randy Mastro, who previously served as former New York City Mayor Eric Adams' first deputy, as a partner and co-chair of the firm's securities and complex litigation practice.
-
January 15, 2026
Ex-CEO Of COVID Vax Maker Accused Of Insider Trading
New York Attorney General Letitia James on Thursday sued the former CEO of healthcare contractor Emergent BioSolutions Inc., alleging insider trading amid troubles manufacturing a COVID-19 vaccine, while signing a $900,000 settlement with the company over its approval of an executive trading plan.
-
January 15, 2026
Dems Push SEC To Pursue Crypto Case Against Justin Sun
Three House Democrats on Thursday pressed the U.S. Securities and Exchange Commission to reinvigorate its paused enforcement case against Tron founder Justin Sun and address their concerns that the agency's wave of crypto case dismissals coincided with considerable industry donations to President Donald Trump.
-
January 15, 2026
Chancery Tosses Vividion IP Suit Over $2B Bayer Deal
The Delaware Chancery Court on Thursday dismissed a biotech investor's suit accusing the co-founder of Vividion Therapeutics Inc. and others of diverting valuable intellectual property ahead of the company's $2 billion sale to Bayer Corp., finding the alleged misconduct could not have affected the merger price or process under Delaware law.
-
January 15, 2026
Nvidia Sued In Del. For US 'Tax' On Chip Deal With China
Alleging possible company conflicts of interest and unlawful agreements involving the White House and Commerce Department, two NVIDIA Corp. stockholders sued the company late Wednesday for records involving company agreements to pay the U.S. Department of Commerce percentages of high-end graphics processing chip sales to buyers in China.
-
January 15, 2026
Crypto Lender Nexo Fined $500K For Unlicensed Loans
The California Department of Financial Protection and Innovation announced that crypto-backed loan company Nexo Capital Inc. will pay a $500,000 penalty to settle claims it did not have a valid license when making its high-risk loans to California residents.
-
January 15, 2026
Trucking Brokers Ordered To Pay $1.5M Over Ponzi Scheme
A Florida federal judge on Thursday ordered two men connected to a scheme involving a trucking and logistics business to pay nearly $1.5 million to the U.S. Securities and Exchange Commission, which accused the pair of illegally selling most of the $112 million worth of unregistered securities to victims in a fraud targeting Haitian Americans.
-
January 15, 2026
DOL's Benefits Arm Describes New Enforcement Focus
The U.S. Department of Labor's employee benefits arm Thursday outlined a shift in its enforcement priorities, including by ending a focus on employee stock ownership plans.
-
January 15, 2026
SEC Taps Ex-BlackRock, GSA Atty To Be General Counsel
The U.S. Securities and Exchange Commission announced Thursday a former BlackRock senior attorney and U.S. General Services Administration top lawyer will be its next general counsel, as the agency gets underway with a regulatory agenda that prioritizes easing administrative burdens and facilitating capital formation.
-
January 15, 2026
7th Circ. Backs $22M Restitution For Convicted Fraudster
The Seventh Circuit on Wednesday affirmed a lower court's order that a man convicted of a fraudulent investment scheme causing investors to lose roughly $23 million must fork over $21.6 million in restitution, finding he had waived his challenge to the amount the district judge credited for what had already been recovered.
-
January 15, 2026
NY Bill Criminalizes Unlicensed Cryptocurrency Businesses
Manhattan District Attorney Alvin Bragg and New York State Sen. Zellnor Myrie on Thursday announced a proposed law to criminalize operating a cryptocurrency business without a license, saying crypto has become an "ideal vehicle for money laundering."
Expert Analysis
-
Dropped Case Shows SEC Focus On Independent Directors
The U.S. Securities and Exchange Commission's recent liquidity rule case against Pinnacle Advisors, despite its dismissal by the commission, serves as a reminder that the SEC expects directors to embrace their role as active, probing fiduciaries, says Dianne Descoteaux at MFDF.
-
How Crypto Embrace Will Affect Banks And Credit Unions
The second Trump administration has moved aggressively to promote crypto-friendly reforms and initiatives, and as the embrace of stablecoins and distributed ledger technology grows, community banks and credit unions should think strategically as to how they might use these innovations to best serve their customers, says Jay Spruill at Woods Rogers.
-
Navigating The SEC's Evolving Foreign Private Issuer Regime
As the U.S. Securities and Exchange Commission reevaluates foreign private issuer eligibility, FPIs face not only incremental compliance costs but also a potential reshaping of listing strategies, capital access, enforcement exposure and global regulatory coordination, potential unintended effects that deserve further exploration, say attorneys at Simpson Thacher.
-
Opinion
Expert Reports Can't Replace Facts In Securities Fraud Cases
The Ninth Circuit's 2023 decision in Nvidia v. Ohman Fonder — and the U.S. Supreme Court's punt on the case in 2024 — could invite the meritless securities litigation the Private Securities Litigation Reform Act was designed to prevent by substituting expert opinions for facts to substantiate complaint assertions, say attorneys at A&O Shearman.
-
Opinion
High Court, Not A Single Justice, Should Decide On Recusal
As public trust in the U.S. Supreme Court continues to decline, the court should adopt a collegial framework in which all justices decide questions of recusal together — a reform that respects both judicial independence and due process for litigants, say Michael Broyde at Emory University and Hayden Hall at the U.S. Bankruptcy Court for the District of Delaware.
-
What Cross-Border Task Force Says About SEC's Priorities
The formation of the U.S. Securities and Exchange Commission's cross-border task force, focused on investigating U.S. federal securities law violations overseas, underscores Chairman Paul Atkins' prioritization of classic fraud schemes, particularly involving foreign entities, say attorneys at Cleary.
-
Series
Traveling Solo Makes Me A Better Lawyer
Traveling by myself has taught me to assess risk, understand tone and stay calm in high-pressure situations, which are not only useful life skills, but the foundation of how I support my clients, says Lacey Gutierrez at Group Five Legal.
-
6th Circ. FirstEnergy Ruling Protects Key Legal Privileges
The Sixth Circuit’s recent grant of mandamus relief in In re: First Energy Corp. confirms that the attorney-client privilege and work-product protections apply to internal investigation materials, ultimately advancing the public interest, say attorneys at Cooley.
-
Del. Ruling Reaffirms High Bar To Plead Minority Control
The Delaware Court of Chancery's recent decision in Witmer v. Armistice maintains Delaware's strict approach to control and provides increased predictability for minority investors in their investment and corporate governance decisions, says Elena Davis at Ropes & Gray.
-
Series
Law School's Missed Lessons: Client Service
Law school teaches you how to interpret the law, but it doesn't teach you some of the key ways to keeping clients satisfied, lessons that I've learned in the most unexpected of places: a book on how to be a butler, says Gregory Ramos at Armstrong Teasdale.
-
How Occasional Activists Have Reshaped Proxy Fights
The sophistication and breadth of first-time activist engagement continue to shape corporate governance and strategic outcomes, as evidenced across corporate annual meetings this summer, meaning advisers should anticipate continued innovation in tactics, increased regulatory complexity, and a persistent focus on board accountability, say attorneys at MoFo.
-
US-German M&A Hits Its Stride Despite Economic Headwinds
Against expectations, dealmakers in both the U.S. and Germany are actively seeking investment opportunities in each other's markets, with 2025 shaping up to be the strongest year in recent memory, say attorneys at White & Case.
-
Enter The Wu-Tang Ruling That May Change Trade Secret Law
A New York federal court's recent holding that a Wu-Tang Clan album qualifies as a trade secret provides the first federal framework for analyzing trade secret claims involving assets valued primarily for exclusivity, potentially reshaping Defend Trade Secrets Act jurisprudence for the digital economy, says Jason Bradford at Jenner & Block.
-
How Financial Cos. Can Prep As NYDFS Cyber Changes Loom
Financial institutions supervised by the New York State Department of Financial Services can prepare for two critical cybersecurity requirements relating to multifactor authentication and asset inventories, effective Nov. 1, by conducting gap analyses and allocating resources to high-risk assets, among other steps, say attorneys at Pillsbury.
-
Opinion
Ending Quarterly Reporting Would Erode Investor Protection
President Donald Trump recently called for an end to the long-standing practice of corporate quarterly reporting, but doing so would reduce transparency, create information asymmetries, provide more opportunities for corporate fraud and risk increased stock price volatility, while not meaningfully increasing long-term investments, say attorneys at Bleichmar Fonti.